百克生物
(688276)
| 流通市值：61.35亿 | | | 总市值：61.35亿 |
| 流通股本：4.14亿 | | | 总股本：4.14亿 |
| 利润表 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 营业总收入 | 147,351,373.49 | 605,072,927.68 | 474,442,765.98 | 284,896,170.67 |
| 营业总成本 | 150,517,283.29 | 846,820,195.84 | 628,977,112.72 | 382,049,170.48 |
| 其他经营收益 | | | | |
| 营业利润 | -7,674,272.41 | -332,325,649.25 | -226,720,962.84 | -107,964,571.97 |
| 利润总额 | -7,543,845.22 | -331,903,612.67 | -204,575,646.81 | -99,605,999.47 |
| 净利润 | -3,474,143.66 | -262,580,724.19 | -158,250,519.93 | -73,573,428.04 |
| 每股收益 | | | | |
| 其他综合收益 | -2,189,991.99 | -11,697,785.17 | -9,002,103.61 | -6,633,894.84 |
| 综合收益总额 | -5,664,135.65 | -274,278,509.36 | -167,252,623.54 | -80,207,322.88 |
| 资产负债表 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 流动资产: | | | | |
| 流动资产合计 | 1,480,079,097.45 | 1,422,924,819.47 | 1,635,849,991.63 | 1,781,073,841.68 |
| 非流动资产: | | | | |
| 非流动资产合计 | 3,647,805,025.57 | 3,645,496,458.63 | 3,574,346,652.42 | 3,483,613,431.07 |
| 资产总计 | 5,127,884,123.02 | 5,068,421,278.1 | 5,210,196,644.05 | 5,264,687,272.75 |
| 流动负债: | | | | |
| 流动负债合计 | 1,154,932,568.13 | 1,104,841,413.73 | 1,172,887,445.14 | 1,076,002,405.05 |
| 非流动负债: | | | | |
| 非流动负债合计 | 127,583,639.27 | 112,631,984.9 | 79,709,966.36 | 117,372,380.72 |
| 负债合计 | 1,282,516,207.4 | 1,217,473,398.63 | 1,252,597,411.5 | 1,193,374,785.77 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 3,845,367,915.62 | 3,850,947,879.47 | 3,957,599,232.55 | 4,071,312,486.98 |
| 股东权益合计 | 3,845,367,915.62 | 3,850,947,879.47 | 3,957,599,232.55 | 4,071,312,486.98 |
| 负债和股东权益合计 | 5,127,884,123.02 | 5,068,421,278.1 | 5,210,196,644.05 | 5,264,687,272.75 |
| 现金流量表 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 196,553,655.09 | 1,206,355,425.95 | 796,730,217.89 | 496,736,522.2 |
| 经营活动现金流出小计 | 177,868,066.7 | 975,148,367.78 | 811,539,568.49 | 487,417,259.09 |
| 经营活动产生的现金流量净额 | 18,685,588.39 | 231,207,058.17 | -14,809,350.6 | 9,319,263.11 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 19,300 | 64,400.01 | - | - |
| 投资活动现金流出小计 | 76,046,956.07 | 456,486,505.07 | 286,791,093.25 | 190,457,558.92 |
| 投资活动产生的现金流量净额 | -76,027,656.07 | -456,422,105.06 | -286,791,093.25 | -190,457,558.92 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 126,165,360.47 | 334,651,920.07 | 269,084,835.71 | 192,429,017.08 |
| 筹资活动现金流出小计 | 54,522,529.19 | 247,274,830.95 | 149,172,656.33 | 103,702,533.55 |
| 筹资活动产生的现金流量净额 | 71,642,831.28 | 87,377,089.12 | 119,912,179.38 | 88,726,483.53 |
| 汇率变动对现金及现金等价物的影响 | -72,815.24 | -158,504.54 | -105,967.58 | -62,914.32 |
| 现金及现金等价物净增加额 | 14,227,948.36 | -137,996,462.31 | -181,794,232.05 | -92,474,726.6 |
| 期末现金及现金等价物余额 | 215,465,506.39 | 201,237,558.03 | 157,439,788.29 | 246,759,293.74 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -137,996,462.31 | - | -92,474,726.6 |
最新报告期：2026-04-28| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 中信证券 | 宋硕,陈竹 | -0.22 | -0.03 | 0.07 | 2026-04-28 |